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Abstract
The number of new technologies emerging each year in the realm of dental caries management is
growing at an exponential rate. Examining the patent literature, one can see that this growth rate
will likely continue, with the outcome that dentistry will see an expanded growth in managing dental
caries by risk assessment with medicinal therapeutic interventions. Restorative dentistry solutions,
treating the results of dental caries, will continue to grow, while technologies to identify the caries
process at its earliest stages will soon invade practices everywhere. The most interesting aspect of
these changes will be how industry responds to the inexorable, yet slow change in dental
professional demand for these new technologies, while trying to be the "first to market" within the
various categories of this business opportunity. This paper will take a close look at how businesses
with the core competence to be key players in this emerging growth category will assess the
marketplace, and match up their business interests with the changing needs of the dental
profession. The paper will also address the strategic planning and business processes that the dental
industry will undertake to bring new technologies to market, and how these technologies will be
positioned to health care professionals and consumers. The results of the key interactions between
industry and the dental profession will determine the extent to which dental caries is managed as
a disease, in addition to being managed by surgical restorative interventions.
Introduction
Although dental caries is the most prevalent infectious
disease in humans, affecting 97% of the population in
their lifetimes, we primarily treat the effects of dental car-
ies, and not the disease itself. Most restorative dentistry,
most prosthodontics in adults, and most endodontics are
related to the results of dental caries, not the disease proc-
ess itself. We are, in general, limited to surgical restorative
intervention because we have historically lacked clinical
caries detection tools sensitive enough to see a caries
lesion so early that we can treat it with medicinal thera-
peutic approaches. Such remineralization techniques are
well established scientifically in vitro, but have escaped
routine clinical use because of the void of early detection
methods that are clinically feasible.
In addition, when it comes to reducing the risk of caries
within populations, or groups of patients within a prac-
tice, we have, in general, provided empirical standardized
recommendations, such as "brush and floss" and "use flu-
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oride toothpaste." Although such methods of interven-
tion to reduce caries risk are extremely effective within
populations at risk, these routine measures do not target
individual patients who may be at much greater than aver-
age risk. New ways of thinking combined with new tech-
nologies will dramatically change the way we deal with
dental caries. Managing the disease process by mitigating
risk instead of identifying the disease at a later stage
requiring surgical restorative intervention will soon
become the norm. To date, the dental industry has not
focused much attention on the disease – dental caries –
but has focused its attention on the results of the disease
– cavities.
The "gross domestic product" of dentistry stands at
around $80 billion per year in the US. The dental business
in the US is growing at a rate greater than the economy as
a whole. The majority of dental expenditures (80 percent)
are via professional services, with only 12 percent of
expenditures for consumer products (toothpastes,
mouthrinses, etc.) and 8 percent for professional products
(consumables and equipment used by dental practices in
delivering care). When examining the $80 billion from
the perspective of the reason for the expenditure, it is
apparent from various industry reports that about 60% of
the total expenditure, or approximately $48 billion dol-
lars per year in the US, is spent on treating the "effects" or
"results" of dental caries. As noted above, the vast major-
ity of caries expenditures (most restorative dentistry) do
not treat the disease but provide surgical repair for the
damage done by the disease. The reason is that to date
dentists have not possessed the necessary tools to detect
the caries process on a site-specific basis until such a late
stage that surgical intervention is the only available
approach.
Indeed, the caries detection devices most of us are using
today are extremely insensitive. Visual examination, using
explorer and/or mirror usually can identify caries lesions
only when restorative intervention is needed. Radiogra-
phy is also extremely insensitive. Dentists can see caries
lesions interproximally on bitewing radiographs only
when they are at least halfway through the enamel. This
limitation causes us to miss many lesions at the earliest
stages, the time when remineralization techniques might
be effective. Transillumination to identify caries lesions in
anterior teeth has been used for a long time; however,
such detection is limited to identifying lesions that are
already extensive in their progress through the enamel on
the way to cavitation.
In summary, we have been historically unable to detect
caries lesions early and subcategorize our patients into
various risk categories. The changes that have happened
and that will transpire in this arena will change dentistry
perhaps more than any change to date.
Sensitivity, Specificity, and Reliability
When assessing new caries detection tools, one must eval-
uate them based on several important criteria, including
sensitivity and specificity. I will not provide a complicated
mathematical definition of these terms, but will rather
provide a working definition that is important in the way
clinicians should think about such tools.
Sensitivity refers to the ability of the tool or device to iden-
tify the presence of the condition when it does indeed
exist. In other words, are there any false negatives? By this
measure, as mentioned above, we know that all of the
tools that have historically been available to us are
extremely insensitive. Included in this list of insensitive
dental caries detection tools are (1) visual examination,
(2) radiography, and (3) unaided transillumination. The
absence of highly sensitive devices in the marketplace for
caries detection has perpetuated the scenario wherein sur-
gical restorative intervention is general the only option.
Specificity refers to the ability of the tool or device to be
accurate in its identification of a condition when it detects
such a condition. In other words, are there false positives?
There are two parts of the specificity equation to think
about. The first: Is what I have detected indeed what I
believe it to be? If a radiograph or visual examination
detects what is believed to be a caries lesion, how certain
can one be that what is detected is indeed a caries lesion?
The second important part of specificity, which will
become even more important to us as we begin to detect
caries lesions at a very early stage, is: Will the detected
lesion progress if untreated? This is, perhaps, the more dif-
ficult challenge. The earlier we detect caries lesions, the
greater the risk that we will detect lesions that may not
have progressed to a stage requiring surgical restorative
intervention. The natural compensatory remineralization
process might allow routine "reversal" of very small
lesions by "naturally occurring" remineralization. This
second aspect of specificity – will the lesion progress if
untreated? – is important to understand. Having said this,
the author and most experts in the area are not too con-
cerned about employing remineralization techniques for
early detected small lesions, even at the risk of treating
some that may not have progressed if untreated. The
greater concern is if these early lesions are treated via sur-
gical restorative interventions when they either (1) might
not progress at all or, (2) might be (in the near future)
treatable with medicinal remineralization approaches.
The marketplace will ultimately not be receptive to these
newer highly sensitive tools, even with increased specifi-BMC Oral Health 2006, 6:S6
Page 3 of 6
(page number not for citation purposes)
city, unless the appropriate compensation systems are in
place. Third party payors are not currently positioned to
reimburse for remineralization therapies; in fact, they do
not yet reimburse for detection techniques that might
obviate the need for radiographs (currently, a billable
service).
Risk Assessment Tools
There are a variety of means available today to assess the
risk of patients for dental caries. These tools can be
grouped into two distinct areas. First, those that gather
historical and environmental data and determine a risk
level based on this data; second, those that employ vari-
ous forms of technology by assessing one or more distinct
outcome measures as validated determinants of risk [1,2].
History and Environment Tools
Featherstone [3-5] and others have developed a risk
assessment tool that offers separate sections for adults and
children. This tool includes historical factors, environ-
mental factors, and uses some technology to assess such
factors as bacterial counts and salivary flow rates. There is
little information validating the use of bacterial counts,
salivary flow rates, and buffering capacities in children.
The American Academy of Pediatric Dentistry (AAPD) has
recently published a caries assessment tool (CAT) [6] that
allows the clinician to assign a relative risk to a child by
virtue of historical and environmental data collection. The
greatest risk factor for caries is a history of caries. Even if a
child has had a single surface caries lesion, the risk for
future caries is dramatically increased [7]. Additionally, a
history of caries in the family, in particular in the mother,
will increase the caries risk in the child. This CAT is very
useful in caries risk assessment for children, although it
does require several minutes of time in the office to gather
the needed data.
The marketplace of dentistry that includes the patient, the
dental professional, and third party payors must convene
regular discussions to allow payment for important serv-
ices that will lead to this "new kind of dentistry" in which
patients are offered highly valuable screening services
such as risk assessment and subsequent medicinal and
other therapeutic interventions short of surgical restora-
tive intervention. Although it is assumed that most
patients would prefer to receive earlier non-surgical treat-
ments, these treatments will not be universally available
until compensation means are set in place.
Technology Assessment Tools
Besides looking at the environmental conditions and the
history of the patient as a means to determine caries risk,
there are a multitude of technologies in various stages of
development which will aid in predicting future caries.
Over the next several years, outcomes validation data will
emerge to determine which of these technologies or col-
lections of technologies will have greatest predictive
value.
Acid Production Detection
Although there is no technological magic bullet in pre-
dicting caries risk in children, technologies that allow the
measurement of "acid production potential" appear quite
promising. Regardless of the quantity or strain of organ-
isms within a plaque biofilm, the biofilm must be capable
of producing acid upon being challenged with sucrose in
order for the caries process to progress. Therefore, any
device that uses technology to assess the acid production
potential of the biofilm as an "in vitro diagnostic" might
be quite useful in dentistry for children.
A product referred to as "Cariostat" (Dentsply Sankin,
Japan), available in Japan but not in the US, resides in this
category. Shimono and his colleagues at Okayama Uni-
versity have studied this interesting risk assessment tool
and have been able to reliably predict caries risk as meas-
ured by the decayed and filled surfaces (df) outcome
measure [8-10]. The Cariostat test has reliably predicted
caries experience in the short term in toddlers, and in the
long term by sampling as early as age 3 and predicting df
outcomes as long-term as age 10. Additionally, Shimono's
group has shown that aggressive intervention within a
Cariostat elicited high-risk group can prevent subsequent
caries experience in such high risk kids.
Other technologies are currently being developed in the
category of acid production potential. When technologies
within this category are validated via caries outcome
measures, these tools may be extremely useful in a variety
of environments not limited to dental offices. Pediatri-
cians are now required to perform an oral health assess-
ment at 6 months of age, [11] given that they see children
so often at a very young age (15 times or more before age
3). If technology can provide them with a rapid-screening
tool that is reliable, then it might easily be determined
which of the millions of children they see each year need
more immediate referral for intervention and prevention
of dental caries.
QLF (Quantitative Light-Induced Fluorescence
Inspektor Research Systems (Amsterdam) offers another
very interesting technology in the early detection of dental
caries. This device is currently marketed in the US by
OMNII Oral Pharmaceuticals. It is being used in a variety
of laboratory and clinical trials to identify caries lesions at
a very early stage. Because of its ability to detect caries
early and on a lesion-specific basis, it will likely precipi-
tate the development of new drugs for early stage interven-
tion, prior to the need for restorative treatment. The QLF
device transmits light to evoke fluorescence. A collectionBMC Oral Health 2006, 6:S6
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component receives the fluoresced tooth data and calcu-
lates demineralization. In the case of QLF, the device uses
a halogen light within the visible frequency and "scans"
the tooth surface, providing an image of the entire tooth.
The intellectual property of this device resides in its ana-
lytic software that can provide a very detailed analysis of
the demineralization level of very early lesions, and can
also "superimpose" scans over previous scans of the same
lesion in order to identify the effects of treatment. When
perfected clinically, this device may be exceptionally
important to clinicians in the early detection and individ-
ualized management of caries lesions with remineraliza-
tion approaches. Studies have already shown that QLF
might be useful in monitoring lesions while engaging in
remineralization therapies.
Caries Management with Fluoride Interventions
Other papers in this publication deal with fluoride and
other medicinal interventions for caries management.
Because we now live in a world where caries can be
detected before restoration is warranted, the obvious
question that arises after early detection is, "Now what do
I do"?
A variety of intervention measures are currently available,
and many more are being developed [12-14]. Many of
these interventions are using products we have in our pos-
session, such as fluorides in various forms. Fluoride var-
nish, a new member of the preventive armamentarium,
might be the precursor to soon-to-be-available varnish
type interventions employing other agents instead of, or
The Caries Evolution Figure 1
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in addition to, fluoride. We may also see the development
of lesion-specific treatments that are professionally
applied, in combination with individually tailored home
care programs for the parents and the child [15-25]. By
detecting caries lesions and/or caries risk at the earliest
stages, we can better empower families to manage their
children's oral health in concert with the professional
office team and its efforts. When technology routinely
allows us to inform parents of their child's risk level, as
well as to inform them of the specific locations where
early caries activity is occurring, it is certain that families
will feel a greater sense of obligation to take part in pre-
venting progression of disease.
As we are able to detect the risk of caries and caries-specific
lesions earlier, the dental industry will incorporate vari-
ous new areas of scientific discovery to yield products
along the continuum of development of caries (Figure 1).
The "caries evolution" process notes various stages along
the pathway of caries development where intervention
products might be created. Any product developed to be
used in the lower left quadrant of this chart provides a
solution that is implemented prior to restorative dentistry.
Given new discoveries in biofilm research, as well as in
perfecting remineralization techniques, clearly there is sig-
nificant product development opportunity. Only the
compensation/reimbursement mechanisms will need to
be put in place.
Access to Care/the Silent Epidemic
In 2000, the Surgeon General of the United States, in the
first ever Surgeon General's Report on Oral Health, [26]
called dental caries in children "the silent epidemic."
Included in this report was a detailed explanation of the
access to care problem in this country. Eighty percent of
dental disease occurs in 25% of the population, and it is
this affected segment that least frequently has access to
care. It is therefore essential that general practitioners and
pediatric dentistry join forces in gaining access to care for
all children. Given the growing number of courses, educa-
tional materials online, and efforts to train general den-
tists in the care of young children, we are all better
enabled to bring children into our practices and to man-
age the solution to this problem.
Conclusion
There are exciting times ahead in dentistry and, in partic-
ular, in caring for children. One of the features of this
exciting present and future is the increased facility of man-
aging caries as a disease, and not merely treating its
results. It is clear that the years ahead will bring better and
more powerful caries risk assessment tools and detection
devices, all yielding more effective therapeutic interven-
tions. How the marketplace will evolve to allow for these
changes is unclear, but clearly the consumer/patient, den-
tal professionals, and the dental pharmaceutical industry
will play important roles. Just as the medical pharmaceu-
tical business talks directly to the consumer to promote
various drugs, so, too will dental professionals and the
dental pharmaceutical industry. As opportunities become
identified to create new drugs to deal with caries as a dis-
ease, treating it before surgical restorative intervention is
needed; clearly the interaction of these three players in the
marketplace will yield major changes in the dental indus-
try as a whole.
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